Home   About this service   Get the news  
+32 2 743 34 03

 Belgium  Other Countries
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
Gimv [BE0003699130/GIMB]   
[05/09/2019]

Gimv : iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment

Antwerp, 5 September, 8:00 AM CET iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment iSTAR Medical SA, a Wavrebased private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announces the completion of a EUR 40.1... See more
 
Gimv [BE0003699130/GIMB]   
[30/07/2019]

Gimv : AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection.

Antwerp BE, 30 July 2019, 8:00 CET AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection Gimv is increasing its commitment to AgroSavfe, an innovative food and agrobiotech company developing environmentally friendly plant protection products. As... See more
 
Gimv [BE0003699130/GIMB]   
[30/07/2019]

Gimv : Gimv sells stake in thinkstep AG, the Stuttgart-based specialist in sustainability software.

Munich/Stuttgart, 30. July 2019, 7:45 CET Gimv sells stake in thinkstep AG, the Stuttgartbased specialist in sustainability software Gimv, together with all other shareholders, is selling its stake in Stuttgartbased software firm thinkstep AG www.thinkstep.com to US software provider Sphera Solutions. Thanks to the longterm support of all investors,... See more
 
Gimv [BE0003699130/GIMB]   
[30/07/2019]

Gimv : Gimv exits Legallais, ironmongery distributor for building professionals in France.

Antwerpen, 30 July 2019, 7:30 CET Gimv exits Legallais, ironmongery distributor for building professionals in France. Gimv today announced its exit from French company Groupe Legallais, in which it has held a minority stake since February 2016. Founded in 1889, Legallais is a leading independent distributor of ironmongery and finishing work products for... See more
 
Gimv [BE0003699130/GIMB]   
[25/07/2019]

Gimv : Gimv and other shareholders sell biopharmaceutical company Breath Therapeutics to Zambon after a fast development

Antwerp BE / Münich GER, 25 July 2019, 8:00 CET Gimv and other shareholders sell biopharmaceutical company Breath Therapeutics to Zambon after a fast development Today, Gimv, Sofinnova and Gilde Healthcare announced the sale of biopharmaceutical company Breath Therapeutics. Specialising in advanced and firstinclass inhalation therapies for severe respiratory ... See more